ARTL Artelo Biosciences, Inc.: Net earnings per share for the last 12 months

Official company branding of Artelo Biosciences Inc. (ARTL)

Artelo Biosciences drug development is independent of economic cycles and seasonality. Artelo Biosciences aims for leadership in treating cancer-related pain and anorexia without psychoactive effects. The 12-month YoY EPS trend visualizes this dynamic, where the value 82.10 represents the most recent figure. However, regulatory complexities and a rapid cash burn before the completion of Phase II trials create significant risks.

ARTL Artelo Biosciences, Inc. Earnings per share for the last twelve months (02/11/2024 - 11/17/2026)

Artelo - analytical breakdowns and key metrics (ARTL)

- company stock capitalization data:
Initial company analysis:Artelo - ARTL
Manufactured products of Artelo Biosciences Inc.

This indicator captures the annual growth rate of net earnings per share over a rolling twelve-month period. The calculation model reflects profitability dynamics, reacting directly to quarterly reports and financial results. By analyzing the EPS YoY TTM relative change chart, an investor assesses the efficiency of business capitalization. For Artelo Biosciences (ARTL), this metric remains negative due to the absence of commercial products. Constant R&D expenditures preclude operating income, turning the metric into a marker for the capital burn rate.

Competitor analysis

Earnings per share for the trailing year INDV (Indivior plc)|Collegium Corp (COLL) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Cronos|CGC (Canopy Growth Corp.) - Net earnings per share (EPS TTM)|HITI: Earnings per share for the trailing year|Earnings per share for the last twelve months Aurora Cannabis, Inc. (ACB)|Net earnings per share for the last 12 months Achieve Life Sciences, Inc. ACHV|skyebioscience.com - Net earnings per share for the last 12 months|Anebulo (ANEB) - Net earnings per one share for the last twelve months|Canndoc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Earnings per share for the last twelve months|India Globalization Capital - Earnings per share for the trailing year|Earnings per share for the last twelve months MIRA Pharma|FLGC: Earnings per share for the trailing year|Earnings per share for the last twelve months IMC (IMCC)|ADIL: Earnings per one share for the last 12 months|Ensysce Biosciences - Net earnings per share for the last 12 months|Earnings per share for the trailing year TTNP|gnln.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year INM (InMed)|Akanda Corp. (AKAN) - Earnings per share for the last twelve months|ENVB - Net earnings per share for the last four quarters|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO